Hjem › Glioblastom
Glioblastom kliniske forsøg rekrutterer i USA
157 studier for Glioblastom rekrutterer deltagere på steder over hele USA.
Byer med flest studier
- New York City, NY30 studier
- Boston, MA28 studier
- Houston, TX25 studier
- Los Angeles, CA23 studier
- Durham, NC20 studier
- San Francisco, CA17 studier
- Washington, DC15 studier
- Rochester, MN15 studier
- Chicago, IL15 studier
- Miami, FL14 studier
- Columbus, OH14 studier
- Jacksonville, FL13 studier
- Aurora, CO12 studier
- St. Louis, MO12 studier
- Atlanta, GA11 studier
- Salt Lake City, UT11 studier
- Philadelphia, PA11 studier
- Baltimore, MD11 studier
- Cleveland, OH11 studier
- Baldwin Park, CA10 studier
- Pittsburgh, PA9 studier
- Birmingham, AL9 studier
- Dallas, TX9 studier
- Nashville, TN9 studier
- Phoenix, AZ8 studier
- Winston-Salem, NC8 studier
- Seattle, WA8 studier
- San Antonio, TX8 studier
- San Diego, CA7 studier
- Edison, NJ7 studier
- Cincinnati, OH6 studier
- Tampa, FL6 studier
- Madison, WI6 studier
- Ann Arbor, MI6 studier
- Lexington, KY5 studier
- Mountain View, CA5 studier
- Queens, NY5 studier
- Omaha, NE5 studier
- Arlington, VA5 studier
- Charlottesville, VA5 studier
Efter delstat
- Alabama9 studier
- Arizona13 studier
- Californien40 studier
- Colorado14 studier
- Connecticut5 studier
- District of Columbia9 studier
- Florida30 studier
- Georgia12 studier
- Illinois16 studier
- Indiana4 studier
- Iowa4 studier
- Kansas3 studier
- Kentucky5 studier
- Maryland16 studier
- Massachusetts29 studier
- Michigan11 studier
- Minnesota19 studier
- Missouri12 studier
- Nebraska5 studier
- New Jersey8 studier
- New York33 studier
- North Carolina26 studier
- Ohio23 studier
- Oklahoma4 studier
- Pennsylvania21 studier
- Rhode Island3 studier
- South Carolina3 studier
- Tennessee10 studier
- Texas33 studier
- Utah11 studier
- Virginia10 studier
- Washington9 studier
- Wisconsin8 studier
Nyligt opdaterede studier
Officiel studietekst (engelsk)
Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06991101Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT05432804A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT03970447GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07301268GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
RekruttererFase 1
Alder 21 til 70 · Alle køn · Opdateret 30. sep. 2026 · NCT06815432The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07285044Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 29. sep. 2026 · NCT05902169Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07326566A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT05303467Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
RekruttererFase 1/2
Alder 18 til 99 · Alle køn · Opdateret 28. sep. 2026 · NCT07416188Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07145112A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
RekruttererFase 1/2
Op til 25 år · Alle køn · Opdateret 25. sep. 2026 · NCT04094610Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07195591MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT03896568Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT06047379RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)
RekruttererFase 1
Alder 18 til 80 · Alle køn · Opdateret 23. sep. 2026 · NCT06389591OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial
RekruttererFase 2
Alder 18 til 90 · Alle køn · Opdateret 23. sep. 2026 · NCT06558214Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
RekruttererFase 1/2
Alder 18 til 99 · Alle køn · Opdateret 22. sep. 2026 · NCT06814496A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT05765812Anti-GD2 ADC M3554 in Advanced Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT06641908VISTA: Valproic Acid, Irinotecan, and Simvastatin for Recurrent Glioma
RekruttererFase 2
Alder 18 til 98 · Alle køn · Opdateret 21. sep. 2026 · NCT07831369REMIND Maintenance Radiotherapy for Newly Diagnosed Glioblastoma
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT07831772Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT04977375ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT07089641A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
RekruttererFase 1
Alder 19 og opefter · Alle køn · Opdateret 14. sep. 2026 · NCT05698524Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.